Sort   by:  
 Page size 
UnknownT helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.
Not available
S-EPMC5015487 | biostudies-literature
UnknownInternational multi-centre study of pregnancy outcomes with interleukin-1 inhibitors.
Not available
S-EPMC6251516 | biostudies-literature
UnknownSustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study.
Not available
S-EPMC3334655 | biostudies-literature
UnknownAnakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).
Not available
S-EPMC9255857 | biostudies-literature
UnknownAdditive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
Not available
S-EPMC4639987 | biostudies-literature
UnknownCystathionine β-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis.
Not available
S-EPMC8247016 | biostudies-literature
UnknownSomatic Mutations in <i>UBA1</i> and Severe Adult-Onset Autoinflammatory Disease.
Not available
S-EPMC7847551 | biostudies-literature
UnknownCystathionine β-Synthase Deficiency in the E-HOD Registry-Part II: Dietary and Pharmacological Treatment.
Not available
S-EPMC11729643 | biostudies-literature
UnknownEffect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8293025 | biostudies-literature
UnknownFive-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Not available
S-EPMC11894486 | biostudies-literature
Sort   by:  
 Page size